BLUE GOLD LTD-CL A (BGL) Fundamental Analysis & Valuation

NASDAQ:BGL • KYG1331C1042

Current stock price

1.29 USD
-0.11 (-7.86%)
Last:

This BGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BGL Profitability Analysis

1.1 Basic Checks

  • BGL had negative earnings in the past year.
  • In the past year BGL has reported a negative cash flow from operations.
BGL Yearly Net Income VS EBIT VS OCF VS FCFBGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • The Return On Assets of BGL (-34.44%) is worse than 85.35% of its industry peers.
Industry RankSector Rank
ROA -34.44%
ROE N/A
ROIC N/A
ROA(3y)-142.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BGL Yearly ROA, ROE, ROICBGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BGL Yearly Profit, Operating, Gross MarginsBGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BGL Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BGL remains at a similar level compared to 1 year ago.
  • BGL has a better debt/assets ratio than last year.
BGL Yearly Shares OutstandingBGL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
BGL Yearly Total Debt VS Total AssetsBGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • BGL has an Altman-Z score of -1.55. This is a bad value and indicates that BGL is not financially healthy and even has some risk of bankruptcy.
  • BGL's Altman-Z score of -1.55 is on the low side compared to the rest of the industry. BGL is outperformed by 87.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.55
ROIC/WACCN/A
WACCN/A
BGL Yearly LT Debt VS Equity VS FCFBGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 0.07 indicates that BGL may have some problems paying its short term obligations.
  • BGL has a worse Current ratio (0.07) than 93.63% of its industry peers.
  • A Quick Ratio of 0.07 indicates that BGL may have some problems paying its short term obligations.
  • BGL has a Quick ratio of 0.07. This is amonst the worse of the industry: BGL underperforms 93.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
BGL Yearly Current Assets VS Current LiabilitesBGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BGL Growth Analysis

3.1 Past

  • BGL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3360.91%.
EPS 1Y (TTM)-3360.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 66.09% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y10.93%
EPS Next 3Y99.08%
EPS Next 5Y66.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BGL Yearly Revenue VS EstimatesBGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 200M 400M 600M
BGL Yearly EPS VS EstimatesBGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. BGL Valuation Analysis

4.1 Price/Earnings Ratio

  • BGL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGL Price Earnings VS Forward Price EarningsBGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGL Per share dataBGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • BGL's earnings are expected to grow with 99.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.93%
EPS Next 3Y99.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BGL Dividend Analysis

5.1 Amount

  • BGL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BGL Fundamentals: All Metrics, Ratios and Statistics

BLUE GOLD LTD-CL A

NASDAQ:BGL (3/19/2026, 12:54:07 PM)

1.29

-0.11 (-7.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.25%
Inst Owner Change363.32%
Ins Owners44.57%
Ins Owner ChangeN/A
Market Cap42.47M
Revenue(TTM)N/A
Net Income(TTM)-11.64M
AnalystsN/A
Price Target20.4 (1481.4%)
Short Float %6.51%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS-0.44
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-142.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 594.15%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -1.55
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3360.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.86%
EPS Next YN/A
EPS Next 2Y10.93%
EPS Next 3Y99.08%
EPS Next 5Y66.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2728.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y56.82%
EBIT Next 5Y91.9%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BLUE GOLD LTD-CL A / BGL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BLUE GOLD LTD-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to BGL.


What is the valuation status for BGL stock?

ChartMill assigns a valuation rating of 1 / 10 to BLUE GOLD LTD-CL A (BGL). This can be considered as Overvalued.


How profitable is BLUE GOLD LTD-CL A (BGL) stock?

BLUE GOLD LTD-CL A (BGL) has a profitability rating of 0 / 10.


Can you provide the financial health for BGL stock?

The financial health rating of BLUE GOLD LTD-CL A (BGL) is 1 / 10.